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Abstract 
Schmallenberg virus (SBV) is an Orthobunyavirus that induces abortion, stillbirths and congenital malformations 
in ruminants. SBV infection induces a long lasting seroconversion under natural conditions. The persistence of the 
protective immunity and the isotype specific antibody response upon SBV infection of sheep has however not been 
studied in detail. Five sheep were kept in BSL3 facilities for more than 16 months and subjected to repeated SBV 
infections. Blood was regularly sampled and organs were collected at euthanasia. The presence of SBV RNA in serum 
and organs was measured with quantitative real-time PCR. The appearance and persistence of neutralizing and SBV 
nucleoprotein (N) isotype specific antibodies was determined with virus neutralization tests (VNT) and ELISAs. The 
primo SBV infection protected ewes against clinical signs, viraemia and virus replication in organs upon challenge 
infections more than 15 months later. Production of neutralizing SBV specific antibodies was first detected around 
6 days post primo-inoculation with VNT and correlated with the appearance of SBV-N specific IgM antibodies. These 
IgM antibodies remained present for 2 weeks. SBV-N specific IgG antibodies were first detected between 10 and 21 
dpi and reached a plateau at 28 dpi. This plateau remained consistently high and no significant decrease in titre was 
found over a period of more than 1 year. Similar results were found for the neutralising antibody response. In conclu-
sion, the SBV specific IgM response probably eliminates SBV from the blood and the protective immunity induced by 
SBV infection protects sheep against reinfection for at least 16 months.
© 2015 Poskin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Schmallenberg virus (SBV) is an Orthobunyavirus 
belonging to the family Bunyaviridae that emerged in 
continental Europe in 2011 [1]. It is a vector borne dis-
ease of ruminants and transmitted by small hematopha-
gous insects called Culicoides [2]. Shortly upon infection, 
a viraemia develops that lasts four to 5 days and can coin-
cide with a drop of milk production, diarrhoea and hyper-
thermia in adult cattle [3]. In sheep, clinical symptoms 
were never reported in adult animals under natural 
conditions and only few symptoms were described after 
experimental infection [1, 4]. Abortion, stillbirths and 
malformations can be observed in offspring upon SBV 
infection of pregnant cattle, sheep and goat [5].
Orthobunyaviruses have an RNA genome consisting 
of three segments named according to their size small 
(S), medium (M) and large (L). The S-segment encodes 
a non-structural protein (NSs) and a nucleoprotein (N), 
which is later associated with the genome in a ribonu-
cleoprotein complex. The M-segment encodes two gly-
coproteins that are present in the viral envelope (Gn and 
Gc) and a non–structural protein (NSm). The L-segment 
encodes the RNA-dependent RNA polymerase (L) [6].
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Commercial ELISA’s have been used to measure SBV-
specific antibody production and they allowed detect-
ing seroconversion in sheep 10 to 14 days post-infection 
(dpi) under experimental conditions [4, 7]. Despite a 
good concordance between ELISA and virus neutrali-
sation tests (VNT), VNT has been shown to be more 
sensitive than the commercial ELISA [8–10]. Virus neu-
tralisation test reported in literature were conducted with 
heat-inactivated serum (30  min at 56  °C) [8, 9, 11–16]. 
Heat-treatment of serum before VNT is a routine prac-
tice aiming to inactivate the complement system and is 
recommended by the OIE for SBV VNT [17].
Schmallenberg virus specific antibodies are known to 
persist at least 12–24 months in cattle after natural infec-
tion [13, 18]. Also in sentinel sheep herds it was observed 
that SBV-specific antibodies could last for at least 
12 months [19]. Although these studies show that SBV-
specific antibodies can last for a long time under natural 
conditions, one cannot exclude that multiple infections 
occurred, potentially at distinct moments over time. 
Another study suggested that naturally infected sheep 
were protected against clinical symptoms and induction 
of congenital malformations upon experimental reinfec-
tion [15].
Seen the fact that SBV was still circulating in Germany 
and the Netherlands in 2014 [20, 21] and the strong epi-
demiological similarity with Akabane virus, it is to be 
expected that SBV will persist in Europe [3,]. It is there-
fore important to obtain knowledge about the duration of 
the protective immunity and the development and persis-
tence of the antibody response against this virus.
In this study, five ewes were maintained under experi-
mental conditions during more than 1 year and subjected 
to SBV infection. The persistence of the protective immu-
nity, the neutralizing antibody response and the kinetics 
of the isotype-specific antibody response against the SBV 
N protein were studied and quantified.
Materials and methods
Ethical statements
The experiments described hereafter were approved 
by the Ethical Committee of the IPH-VAR (Scientific 
Institute of Public Health-Veterinary and Agrochemical 
Research Centre, number of project: 121017-01).
Animals, housing, inoculum and samples
This study was carried out with five “Mourerous” breed 
ewes between 14 and 17  months old at the moment of 
inoculation. All ewes were virologically and serologically 
negative for SBV at the start, as confirmed by quantitative 
real time polymerase chain reaction (qRT-PCR), VNT 
and ELISA. Ewes were housed together in a stable inside 
biosafety level 3 (BSL-3) facilities in which insect traps 
were used to monitor insects and confirm the absence of 
Culicoides midges throughout the experiment.
The inoculum used in this experience was an infec-
tious bovine serum containing 2 × 103 50% tissue cul-
ture infectious doses/mL (TCID50/mL), as determined 
by end-point titration on baby hamster kidney cells 
that was provided by the Friedrich Loeffler Institute 
(Riems, Greifswald, Germany) [22]. The inoculum is 
known to successfully induce a viraemia followed by a 
seroconversion in sheep upon subcutaneous inocula-
tion with one ml of the described inoculum [10]. Each 
animal was inoculated following the described route 
and dose at different time points. Four ewes (ewe 1 
to 4) were inoculated at the beginning of the experi-
ment (day 0). Ewe 3 and 4 received a booster inocula-
tion 28 days post primo inoculation. The fifth ewe was 
kept as a control animal and was not primo inoculated 
nor received a booster. Thereafter all 5 ewes received a 
challenge inoculation more than 1 year after the primo 
inoculation (Table 1).
The five ewes were clinically examined, the rectal tem-
perature was taken and the blood was collected after 
each inoculation daily during 1  week, then weekly for 
1  month, and monthly thereafter (Figure  1). Serum was 
prepared from the blood by 15  min centrifugation at 
3000  rpm and kept at −80  °C until further analysis. All 
ewes were euthanized 14  days after the challenge and 
the prescapularis lymph nodes, mesenteric lymph nodes, 
ovaries and spleen were collected during autopsy and 
stored at −80 °C until further analysis.
SBV RNA detection in serum and organs with qRT‑PCR
RNA extraction and qRT-PCR on blood and organs were 
conducted as previously described [11]. Briefly, total 
RNA was extracted from 140  µL of serum and eluted 
in 60  µL of elution buffer with the QIAamp Viral RNA 
Mini Kit following manufacturer’s instructions (Qiagen, 
Hilden, Germany). Before extraction, 100 µg of organ was 
homogenized in 1 mL of PBS with Stainless Steel Beads 
(Qiagen, Hilden, Germany) and shaken two times 2 min 
at 25  Hz with the TissueLyser (Qiagen, Hilden, Ger-
many). The homogenate was subsequently centrifuged 
5 min at 10 000 rpm. The total RNA was finally extracted 
from 100  µL of supernatant and eluted in 50  µL RNase 
free water with the RNeasy Mini Kit, following manu-
facturer’s instructions (Qiagen, Hilden, Germany). One 
negative control of extraction was added to each run of 
extraction.
The presence of SBV S-segment (forward primer: 
5′-tcagattgtcatgccccttgc-3′; reverse primer: 5′-ttcggccc-
caggtgcaaatc-3′; probe: FAM-5′-ttaagggatgcacctgggccgatg 
GT-3′-BHQ1 [23]) and the presence of B-actin 
as internal control of extraction (forward primer: 
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5′-cagcacaatgaagatcaagatcatc-3′; reverse primer: 
5′-cggactcatcgtactcctgctt-3′; probe: HEX-5′-
tcgctgtccaccttccagcagcagatgt-3′-BHQ1 [24]) were detected 
in a duplex qRT-PCR carried out with the AgPath-ID one-
step qRT-PCR kit (Life Technologies, California, USA) and 
measured with the LightCycler 480 Real-Time PCR system 
(Roche Applied Science, Indianapolis, USA). One posi-
tive control and one negative control of PCR amplification 
were added to each run of qRT-PCR. Cycle threshold val-
ues were converted into copy number/mL of serum and 
copy number/gr of organ using a standard curve consisting 
of successive ten-fold dilutions of an SBV S-segment RNA 
transcript that was added to each run of the qRT-PCR [10].
Serology
Virus neutralization test was carried out as previously 
described [11] with the exception that all sera were ana-
lysed both without (VNTw/d) and with (VNTd) heat-
inactivation of the complement system (30 min at 56 °C) 
before testing. Briefly, successive two fold dilutions of 
50 µL of sera, from 1/2 to 1/256 onwards, were made in 
50  µL of Dulbecco’s Modified Eagles Medium (Gibco, 
Life Technologies, Ghent, Belgium) supplemented by 
1000 IU penicillin/mL, 50 µg/mL gentamicin (Gibco, Life 
Technologies, Ghent, Belgium) and 250  µg/mL ampho-
tericin B (Gibco, Life Technologies, Ghent, Belgium) 
(DMEM) in Nunc Edge 96-well plates (Thermo scientific, 
Waltham, MA, USA). Fifty microliters of virus solution 
was added to each well and the plate let to incubate one 
hour at 37  °C. Thereafter 100  µL of DMEM with 10% 
foetal calf serum (Gibco, Life Technologies, Ghent, Bel-
gium) and 4 × 106 vero cells/mL were added to each well 
and the plate let to incubate at 37 °C and 5% CO2. After 
four days of incubation, the titre was determined as the 
reciprocal of the highest serum dilution in which no lysis 
plaques could be identified in the cell monolayer under 
the light microscope. Two positive controls and one neg-
ative control were added to each run of VNT. Sera were 
considered to be seronegative if the titre was lower than 4 
(specificity 100%) [11].
The presence of SBV-N specific IgM antibodies was 
assayed with a capture IgM ELISA. ELISA plates coated 
with monoclonal anti-ruminant IgM antibodies, recom-
binant SBV-N-proteins and monoclonal horseradish per-
oxidase (HRP) labeled SBV-N specific antibodies were 
purchased from IdVet (Montpellier, France). Briefly, 
10 µL of serum and 90 µL of dilution buffer were deposed 
in duplicate on the IgM ELISA plate and let to incubate 
45 min at 37 °C. The wells were washed and 100 µL of the 
recombinant SBV N-protein solution was added to one of 
both replicates. One hundred microliter of the dilution 
buffer was added to the other replicate. After an incuba-
tion of 90 min at 37 °C, the wells were washed a second 
time and 100 µL of the ready-to-use conjugate was added 
into the wells and the plate was incubated 30 min at room 
temperature. After washing, 100  µL of the tetrameth-
ylbenzidine (TMB) substrate solution was added to the 
wells. After 15 min incubation in the dark at room tem-
perature, the reaction was stopped by adding 100 µL of 
the stop solution. One positive and one negative control 
were added to each IgM ELISA plate. The control sam-
ples were defined and tested in preliminary experiments. 
The positive control sample consisted of pooled sera col-
lected at 10, 11 and 14 dpi from one ewe inoculated with 
the same inoculum in a different experiment [25]. The 
negative control sample consisted of pooled sera col-
lected from ewes in 2005. The optical density (OD) was 
red at 450 nm with Multiskan Ascent (Thermo Scientific, 
Waltham, MA, USA). The net OD value was calculated 
for each sample as (OD value in the replicate with the 
recombinant SBV N-protein solution—OD value in the 
replicate without the recombinant). The S/P percentage 
was calculated as (net OD value  −  OD negative con-
trol sample)/(OD positive control sample  −  OD nega-
tive control sample) × 100. The test was validated only if 
the ODpos >0.35 and the ODpos/ODneg >3. The cut-off 
value for SBV IgM was calculated based on the obtained 
values of 25 negative samples from the control ewe (ewe 
5) collected before the first inoculation and eight sheep 
sera collected in 2005. The cut-off value was determined 
as the mean S/P value of the 33 negative samples +3 
standard deviations. This interval represents 99.6% of the 
negative samples [26]. To evaluate the impact of heat-
inactivation of serum (30 min at 56 °C) on SBV-N specific 
IgM detectability by ELISA, a selection of samples was 
tested in the IgM ELISA described above without (IgM 
ELISAw/d) and with (IgM ELISAd) heat-inactivation of 
the complement system.
The presence of SBV-N-specific IgG antibodies was 
measured with the ID Screen SBV Indirect test (IdVet, 
Montpellier, France) using an anti-multi-species IgG-
horse radish peroxidase conjugate following manufactur-
er’s instructions [7]. The OD was measured as described 
Table 1 Experimental design
The table indicates the day of inoculation, booster and challenge infection, and 
the day of euthanasia for the five ewes used in this study. Ewe 1 and 2 did not 
receive a booster inoculation. Ewe 5 was not primo-inoculated nor boosted and 
kept as control until the challenge infection 14 days before euthanasia.
Ewe Inoculation Booster Challenge Euthanasia
1 0 – 490 504
2 0 – 392 406
3 0 28 392 406
4 0 28 392 406
5 – – 392 406
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Figure 1 RNAemia and SBV-N-specific antibody response induced by SBV inoculation in sheep. RNAemia (copy/mL of serum) and isotype 
specific antibody response (IgM and IgG) against the SBV-N-protein in five ewes upon inoculation with SBV infectious serum under experimental 
conditions as measured with qRT-PCR and IgM ELISA and IgG ELISA respectively. The cut-off S/P value for the IgM ELISA was 17%, while for the IgG 
ELISA the cut-off value was 27%. Empty circles indicate the time points of SBV primo inoculations, crosses indicate the booster inoculations and 
empty triangles the challenge inoculations.
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above. The S/P percentage was calculated as (OD sam-
ple − OD negative control)/(OD positive control − OD 
negative control)  ×  100. The interpretation prescribed 
by the kit is as follows: negative if S/P ≤  50%, doubtful 
if 50%  <  S/P ≤  60% and positive if S/P  >  60%. We also 
determined a cut-off value our self by testing, 50 field 
collected sera sampled before 2010. The cut-off value 
was determined as the mean S/P value of the 50 sam-
ples ±  3 ×  standard deviation. This interval represents 
99.6% of the negative samples [26].
The concordance between the VNTd and the IgG 
ELISA was determined by dividing the number of sam-
ples for which the same qualitative result was obtained in 
VNTd and the IgG ELISA by the total number of samples 
analysed in both tests.
Statistical analyses
The differences between the mean time needed to detect 
seroconversion with VNTw/d and VNTd, and the mean 
S/P value between IgM ELISAw/d and IgM ELISAd were 
statistically analysed with two samples paired t tests.
A linear mixed model was used (SAS Institute Inc., 
Cary, NC, USA) to estimate the mean effect of time with 
relation to the antibody titres and taking into account the 
correlation of the measurements within each sheep over 
time. The time effect was put as a fixed effect in the model 
and a random intercept was allowed meaning that there 
is an average ELISA titre in the sheep population after 
infection but that there is variability between the sheep. 
An autoregressive working correlation matrix (decreasing 
correlation for further time points) was selected based on 
the AIC (Aikake Information Criterion) value.
For all statistical tests, P values lower than 0.05 were 
considered to be statistically significant.
Results
Clinical impact
No significant clinical impact was noticed and the rec-
tal temperature stayed within the normal range (38.3  °C 
‒ 39.9  °C) throughout the experiment (data not shown) 
[27]. Ewes behaved normally, conserved a good appetite 
and no sign of diarrhoea was noticed until the end of the 
experiment.
RNAemia
All ewes showed a comparable RNAemia that started on 
average 2.2 days post primo inoculation (95% CI 1.6–2.8) 
(Table  2). The RNAemia could be detected with qRT-
PCR during a mean period of 4.6 days (95% CI 3.9–5.3). 
At the peak of RNAemia, the mean number of SBV RNA 
copies per ml of serum was 2 × 108 (95% CI 0–6.5 × 108). 
No viral RNA could be detected in the serum after the 
booster and the challenge inoculations. No RNAemia 
was found in the control ewe before its inoculation at the 
end of the experiment (Figure 1).
Serology
Schmallenberg virus-specific neutralizing antibodies 
were first detected at 6.2 (95% CI 5.2–7.2) and 7.8 (95% 
CI 6.4–9.2) days post primo inoculation when deter-
mined by VNTw/d and VNTd, respectively. This differ-
ence was not significant, although the P value of 0.056 
suggests that seroconversion is detected earlier when 
no heat-inactivation of the serum is performed. After 
seroconversion the titre fluctuated between 4 and 128 
and stayed positive until the end of the experiment. No 
increase in antibody titre was observed after booster or 
challenge infections. When the serum was analysed with-
out decomplementation, three false positive results were 
observed for the control ewe before its first inoculation at 
day 392 (days 8, 10 and 119) (Figure 2).
The cut-off value for the SBV-N-specific IgM ELISA 
was calculated to be 17%. The mean period for the first 
detection of SBV-N-specific IgM was 6.6  days (95% CI 
6.1–7.1) post primo inoculation (Table  2) and SBV-N-
specific IgM remained detectable for about two weeks. 
No production of SBV-N-specific IgM was detected after 
booster and challenge infections in ewes 1–4 (Figure 1). 
Table 2 Period of RNAemia and first day of seroconversion upon SBV inoculation
* 3 low positive results before first inoculation were not taken into account
Five ewes (ewe 1 to 5) were primo inoculated with SBV infectious serum at day 0 of the experiment. The numbers indicate the first and last day of RNAemia and the 
day of first seropositive result measured with virus neutralisation test without (VNTw/d) and with (VNTd) heat-inactivation of the serum. The first seropositive result 
measured with ELISA directed against the SBV N-protein for IgM (IgM ELISA, cut-off 17%) and IgG (IgG ELISA, cut-off 27%) are also given.
Ewe RNAemia (first day) RNAemia (last day) VNTw/d VNTd ELISA IgM ELISA IgG
1 2 7 8 9 7 14
2 2 7 6 9 7 21
3 2 7 6 6 6 11
4 3 7 6 9 7 21
5 2 6 5* 6 6 10
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No significant differences were found between S/P val-
ues obtained with SBV-N-specific IgM ELISA in sera that 
were tested without and with heat-inactivation of the 
complement system.
The cut-off value of the SBV-N-specific IgG ELISA 
was determined to be at 27%. The first positive SBV-N-
specific IgG antibody titre was measured between 10 
and 21 days post primo inoculation in all ewes (Table 2). 
Since blood was only collected weekly after 11 days post 
primo inoculation, it is not possible to pinpoint the sero-
conversion date more precisely. The S/P values reached 
a plateau at 28 dpi. Applying a mixed linear model to 
the data obtained for ewe 1–4 between 28 and 392 dpi 
predicted an average decrease of 0.0204% in ELISA titre 
Figure 2 Neutralizing antibody response induced by SBV inoculation in sheep. SBV-specific neutralizing antibody production in five ewes 
inoculated with SBV infectious serum as measured with virus neutralization tests carried out without (VNTw/d) and with (VNTd) heat-inactivation 
of the complement system. Open circles indicate the time points of SBV inoculations, crosses indicate the time points of booster inoculations and 
open triangles indicate the time points of challenge inoculations.
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per day. This estimate was non-significantly different 
from 0 (P =  0.1734; F value =  3.16), indicating that no 
significant decrease over time in S/P values was found. 
Furthermore, no effect was observed after the booster or 
challenge inoculations with the exception of a small and 
temporal (1–4 days) decrease in the SBV-N specific IgG 
antibodies (Figure 1).
An overall concordance of 92% was found between the 
VNTd and the IgG ELISA. When the cut-off value pre-
scribed by the manufacturer for the IgG ELISA is used, 
ewe 1 only became seropositive after the challenge inoc-
ulation, making that the concordance is reduced to 69% 
in that case).
Necropsy
No lesions were noticed at necropsy in any of the ewes. 
Schmallenberg virus RNA was only detected in the four 
organs collected from the control ewe (ewe 5), which 
was inoculated only once at 14  days before euthanasia: 
mesenteric lymph nodes (8.7 ×  108 copies/gr of organ), 
spleen (2  ×  108 copies/gr), prescapularis lymph node 
(1.6 × 107 copies/gr) and ovary (3.7 × 106 copies/gr).
Discussion
Several studies have shown that natural SBV infection 
and vaccination induces a protective immunity in cattle 
and sheep [13, 15, 28–30] but the duration of this induced 
immunity was not studied in detail. This work evaluated 
the persistence of the protective immunity induced by 
SBV infection of SBV naïve ewes over a period of more 
than 1 year under experimental conditions. This experi-
ment furthermore analysed the kinetics of the isotype 
specific antibody response against the viral N-protein.
It was demonstrated that the immunity that develops 
after a single SBV infection of sheep protects the animal 
against clinical signs, RNAemia and virus replication in 
target organs upon reinfection for at least 15  months. 
This period probably lasts even longer since the infec-
tion was associated with a persistent neutralizing anti-
body response that did not significantly decrease during 
that time period. Although not specifically addressed in 
this study, it seems reasonable to hypothesize that this 
induced immunity capable of preventing RNAemia upon 
reinfection will also protect against transplacental virus 
transmission. Epidemiological data have shown that the 
massive spread of SBV among ruminants during the 
first outbreak season, as evidenced by a very high sero-
prevalence of SBV-specific antibodies, correlated with a 
strongly decreased incidence of congenital malforma-
tions during the next season despite a renewed virus 
circulation [18]. Another interesting consequence of the 
observation that no renewed RNAemia could be detected 
after the booster or challenge inoculations is that the 
short lasting RNAemia of 4 to 5 days after primo infec-
tion is the only time frame in which Culicoides midges 
can take an infectious blood meal and transmit the virus 
towards new hosts.
The long term protection and the fast and persistent 
SBV-specific antibody response after a primo infection of 
sheep indicate further that naïve new-born lambs repre-
sent on the one hand an appropriate target for a sentinel 
monitoring system to detect renewed circulation of the 
virus, but are on the other hand also the most impor-
tant target population for vaccination. Although the long 
term protective effect of vaccination still has to be con-
firmed, it seems the best way to protect livestock against 
SBV related disease for a long period of time [28, 29].
Our results show that the decrease of SBV RNA in 
serum coincides with the appearance of SBV-specific 
neutralizing antibodies as detected by VNT and SBV-
N-specific IgM antibodies as found in ELISA, suggest-
ing that SBV-specific IgM plays an important role in the 
clearance of the virus from the circulation. The obser-
vation that the VNT detects seroconversion around the 
same time as the SBV-N-specific IgM ELISA furthermore 
strongly suggests that the detection of SBV-specific IgM 
by VNT explains the higher sensitivity of VNT to detect 
seroconversion than the commercially available ELISA 
detecting SBV-N IgG as was suggested before [10]. Since 
it has been described for other Orthobunyaviruses that 
also glycoproteins Gn and Gc can be the target of a neu-
tralizing antibody response besides the N-protein [31], it 
will be interesting to study the antibody response against 
both other proteins in the future.
It was observed that seroconversion could be detected 
earlier by VNT in sera that had not been heat-inacti-
vated. This might be explained by the fact that heat treat-
ment of sera could result in a (partial) destruction of IgM 
[32, 33]. The heat-inactivation of the sera had however 
no effect on the SBV-N-specific IgM detection in ELISA. 
Another possible explanation is that a part of the (early) 
SBV-specific antibodies require complement factors to 
fully resort their neutralizing effect as has been shown 
before for the antibody response against several other 
viruses [34–37]. This seems to be supported by the fact 
that VNT titres obtained for untreated sera were often 
higher than those of heat-inactivated sera, also on time 
points when SBV-specific IgM was no longer present. 
Although omitting heat treatment seems to allow detec-
tion of seroconversion earlier by VNT, the occurrence of 
false positive results in the control ewe in our experiment 
suggests keeping the heat-inactivation of sera for VNT in 
place.
The decrease of SBV-N specific IgM at about 2 weeks 
post infection is associated with an increase in SBV-N 
specific IgG. The stable and long lasting (neutralizing) 
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IgG response is in line with VNT results obtained after 
infection of sheep with the related AKAV [38] and sug-
gests a role of these antibodies in the long term protec-
tion against SBV reinfection. Also the cell-mediated 
immunity might play a role in the long term protection, 
but was not addressed in this study. Its importance has 
already been suggested based on the lymphohystiocytic 
infiltration of the white and grey matters in SBV affected 
foetuses [39–41] and it was suggested to be part of the 
protective immunity induced by SBV vaccination [28], 
but its contribution remains to be elucidated.
Our results with the SBV-N-specific indirect IgG 
ELISA highlight that one should be critical when defin-
ing the infection status of an animal which has an S/P 
value close to the cut-off described by the manufacturer. 
Although the cut-off of this commercial IgG ELISA was 
chosen based on results of many serum samples and a 
ROC analysis, ewe 1 from this experiment would have 
been considered as negative or doubtful till the moment 
of the challenge infection. It seems therefore advisable 
that doubtful samples are confirmed in the VNTd. ELISA 
test are however less time consuming and more suitable 
for testing of a large amount of samples and it would also 
be interesting to evaluate the sensitivity of competition 
ELISAs that are currently available since these tend to be 
more sensitive.
Since IgA is known to be mostly present in mucous 
secretions and only at low levels in sheep blood [42], the 
kinetic of this particular antibody isotype was not inves-
tigated. It could be more interesting to test the presence 
of SBV-specific IgA in nasal swabs or milk in the future.
In conclusion, it was shown that a single SBV infection 
of sheep induces a protective immunity that prevents 
against clinical signs, RNAemia and virus transmission 
to organs upon SBV reinfection more than 15  months 
later. The initial clearance of the virus from the blood 
coincided with the appearance of SBV-specific neutraliz-
ing antibodies and SBV-N-specific IgM around one week 
post-infection. Between 2 and 3  weeks post-infection, 
an SBV-N-specific IgG response appeared that reached 
a plateau at 4 weeks post-infection and remained stable 
for more than 1 year. It furthermore showed that despite 
the fact that omitting heat-inactivation of sera allows to 
detect seroconversion about 1  day earlier, the risk for 
false positive results suggests to keep decomplementa-
tion in place when performing VNT.
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